Based on the aggregated intelligence of 135,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, robotic medical device maker Hansen Medical (NASDAQ:HNSN) has earned a respected four-star ranking.

With that in mind, let's take a closer look at Hansen's business and see what CAPS investors are saying about the stock right now.

Hansen facts

Headquarters (founded)

Mountain View, Calif. (2002)

Market Cap

$139.4 million

Industry

Health-Care Equipment

TTM Revenue

$31.1 million

Management

Co-Founder/CEO Dr. Frederic Moll
Co-Founder/Chief Technical Officer Robert Younge

TTM Revenue Growth

90.5%

Cash and Short-term Investments / Debt

$29.3 million / $12.5 million

Competitors

Varian Medical Systems (NYSE:VAR)
Intuitive Surgical (NASDAQ:ISRG)

CAPS Members Bullish on HNSN Also Bullish on

Suntech Power (NYSE:STP)
Apple (NASDAQ:AAPL)

CAPS Members Bearish on HNSN Also Bearish on

Geron (NASDAQ:GERN)
Focus Media (NASDAQ:FMCN)

Sources: Capital IQ, a division of Standard & Poor's, and Motley Fool CAPS. TTM = trailing 12 months.

Over on CAPS, 496 of the 519 members who have rated Hansen -- 97% -- believe the stock will outperform the S&P 500 going forward. These bulls include rockfishcc8 and fburks.

Two weeks ago, rockfishcc8 urged our community to hang on to Hansen: "They had a bad last quarter, but almost everyone did. Look for Hansen to clean up all debt and get a huge push from the health care plan."

In a pitch from late last year, fburks expands on the stock's "Intuitive" nature:

This is a company started by [Intuitive Surgical] founder Fred Moll and the robotic catheter system is currently being used for endovascular procedures. This is a growth industry, but the more exciting prospect is the newer applications of this technology in other fields. A recent article in Urology highlighted an animal study using the robotic catheter system in the ureter for treatment of kidney stones and other conditions. … Intuitive's robotic system got a slow start in vascular and heart procedures, but took off once it was applied in the field of urology. I would expect the same to happen to [Hansen's] robotic system.

What do you think about Hansen, or any other stock for that matter? Make your voice heard on Motley Fool CAPS today. More than 135,000 investors are waiting to hear what you have to say. CAPS is 100% free, so simply click here to get started.